Skip to search formSkip to main contentSkip to account menu

sotrastaurin

An orally available pan-protein kinase C (PKC) inhibitor with potential immunosuppressive and antineoplastic activities. Sotrastaurin inhibits both T… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Prostratin exhibits potent HIV-1 latency reversing activity, yet its molecular mechanism of action has not been defined in detail… 
2012
2012
Diffuse large B-cell lymphoma (DLBCL) comprises the largest group of non-Hodgkin lymphoma (NHL). DLBCL can be classified… 
2012
2012
Background: Sotrastaurin (STN), a novel oral protein kinase C inhibitor, blocks early T-cell activation. Its immunosuppressive… 
Review
2011
Review
2011
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract The activated B… 
2009
2009
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2008
2008
(-)-Epigallocatechin gallate, (-)-Gossypol; Ad.hIFN-beta, AF-37702, Agatolimod sodium, Agomelatine, Alvocidib hydrochloride, ARC…